
[Congressional Bills 113th Congress]
[From the U.S. Government Printing Office]
[S. 252 Enrolled Bill (ENR)]

        S.252

                     One Hundred Thirteenth Congress

                                 of the

                        United States of America


                          AT THE FIRST SESSION

          Begun and held at the City of Washington on Thursday,
           the third day of January, two thousand and thirteen


                                 An Act


 
 To reduce preterm labor and delivery and the risk of pregnancy-related 
    deaths and complications due to pregnancy, and to reduce infant 
        mortality caused by prematurity, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. TABLE OF CONTENTS.
    The table of contents for this Act is as follows:

Sec. 1. Table of contents.

                  TITLE I--PREEMIE ACT REAUTHORIZATION

Sec. 101. Short title.
Sec. 102. Research and activities at the Centers for Disease Control and 
          Prevention.
Sec. 103. Activities at the Health Resources and Services 
          Administration.
Sec. 104. Other activities.

              TITLE II--NATIONAL PEDIATRIC RESEARCH NETWORK

Sec. 201. Short title.
Sec. 202. National Pediatric Research Network.

                     TITLE III--CHIMP ACT AMENDMENTS

Sec. 301. Short title.
Sec. 302. Care for NIH chimpanzees.

                  TITLE I--PREEMIE ACT REAUTHORIZATION

    SEC. 101. SHORT TITLE.
    This title may be cited as the ``Prematurity Research Expansion and 
Education for Mothers who deliver Infants Early Reauthorization Act'' 
or the ``PREEMIE Reauthorization Act''.
    SEC. 102. RESEARCH AND ACTIVITIES AT THE CENTERS FOR DISEASE 
      CONTROL AND PREVENTION.
    (a) Epidemiological Studies.--Section 3 of the Prematurity Research 
Expansion and Education for Mothers who deliver Infants Early Act (42 
U.S.C. 247b-4f) is amended by striking subsection (b) and inserting the 
following:
    ``(b) Studies and Activities on Preterm Birth.--
        ``(1) In general.--The Secretary of Health and Human Services, 
    acting through the Director of the Centers for Disease Control and 
    Prevention, may, subject to the availability of appropriations--
            ``(A) conduct epidemiological studies on the clinical, 
        biological, social, environmental, genetic, and behavioral 
        factors relating to prematurity, as appropriate;
            ``(B) conduct activities to improve national data to 
        facilitate tracking the burden of preterm birth; and
            ``(C) continue efforts to prevent preterm birth, including 
        late preterm birth, through the identification of opportunities 
        for prevention and the assessment of the impact of such 
        efforts.
        ``(2) Report.--Not later than 2 years after the date of 
    enactment of the PREEMIE Reauthorization Act, and every 2 years 
    thereafter, the Secretary of Health and Human Services, acting 
    through the Director of the Centers for Disease Control and 
    Prevention, shall submit to the appropriate committees of Congress 
    reports concerning the progress and any results of studies 
    conducted under paragraph (1).''.
    (b) Reauthorization.--Section 3(e) of the Prematurity Research 
Expansion and Education for Mothers who deliver Infants Early Act (42 
U.S.C. 247b-4f(e)) is amended by striking ``$5,000,000'' and all that 
follows through ``2011.'' and inserting ``$1,880,000 for each of fiscal 
years 2014 through 2018.''.
    SEC. 103. ACTIVITIES AT THE HEALTH RESOURCES AND SERVICES 
      ADMINISTRATION.
    (a) Telemedicine and High-Risk Pregnancies.--Section 330I(i)(1)(B) 
of the Public Health Service Act (42 U.S.C. 254c-14(i)(1)(B)) is 
amended by striking ``or case management services'' and inserting 
``case management services, or prenatal care for high-risk 
pregnancies'';
    (b) Public and Health Care Provider Education.--Section 399Q of the 
Public Health Service Act (42 U.S.C. 280g-5) is amended--
        (1) in subsection (b)--
            (A) in paragraph (1), by striking subparagraphs (A) through 
        (F) and inserting the following:
            ``(A) the core risk factors for preterm labor and delivery;
            ``(B) medically indicated deliveries before full term;
            ``(C) the importance of preconception and prenatal care, 
        including--
                ``(i) smoking cessation;
                ``(ii) weight maintenance and good nutrition, including 
            folic acid;
                ``(iii) the screening for and the treatment of 
            infections; and
                ``(iv) stress management;
            ``(D) treatments and outcomes for premature infants, 
        including late preterm infants;
            ``(E) the informational needs of families during the stay 
        of an infant in a neonatal intensive care unit; and
            ``(F) utilization of evidence-based strategies to prevent 
        birth injuries;''; and
            (B) by striking paragraph (2) and inserting the following:
        ``(2) programs to increase the availability, awareness, and use 
    of pregnancy and post-term information services that provide 
    evidence-based, clinical information through counselors, community 
    outreach efforts, electronic or telephonic communication, or other 
    appropriate means regarding causes associated with prematurity, 
    birth defects, or health risks to a post-term infant;''; and
        (2) in subsection (c), by striking ``$5,000,000'' and all that 
    follows through ``2011.'' and inserting ``$1,900,000 for each of 
    fiscal years 2014 through 2018.''.
    SEC. 104. OTHER ACTIVITIES.
    (a) Interagency Coordinating Council on Prematurity and Low 
Birthweight.--The Prematurity Research Expansion and Education for 
Mothers who deliver Infants Early Act is amended by striking section 5 
(42 U.S.C. 247b-4g).
    (b) Advisory Committee on Infant Mortality.--
        (1) Establishment.--The Secretary of Health and Human Services 
    (referred to in this section as the ``Secretary'') may establish an 
    advisory committee known as the ``Advisory Committee on Infant 
    Mortality'' (referred to in this section as the ``Advisory 
    Committee'').
        (2) Duties.--The Advisory Committee shall provide advice and 
    recommendations to the Secretary concerning the following 
    activities:
            (A) Programs of the Department of Health and Human Services 
        that are directed at reducing infant mortality and improving 
        the health status of pregnant women and infants.
            (B) Strategies to coordinate the various Federal programs 
        and activities with State, local, and private programs and 
        efforts that address factors that affect infant mortality.
            (C) Implementation of the Healthy Start program under 
        section 330H of the Public Health Service Act (42 U.S.C. 254c-
        8) and Healthy People 2020 infant mortality objectives.
            (D) Strategies to reduce preterm birth rates through 
        research, programs, and education.
        (3) Plan for hhs preterm birth activities.--Not later than 1 
    year after the date of enactment of this section, the Advisory 
    Committee (or an advisory committee in existence as of the date of 
    enactment of this Act and designated by the Secretary) shall 
    develop a plan for conducting and supporting research, education, 
    and programs on preterm birth through the Department of Health and 
    Human Services and shall periodically review and revise the plan, 
    as appropriate. The plan shall--
            (A) examine research and educational activities that 
        receive Federal funding in order to enable the plan to provide 
        informed recommendations to reduce preterm birth and address 
        racial and ethnic disparities in preterm birth rates;
            (B) identify research gaps and opportunities to implement 
        evidence-based strategies to reduce preterm birth rates among 
        the programs and activities of the Department of Health and 
        Human Services regarding preterm birth, including opportunities 
        to minimize duplication; and
            (C) reflect input from a broad range of scientists, 
        patients, and advocacy groups, as appropriate.
        (4) Membership.--The Secretary shall ensure that the membership 
    of the Advisory Committee includes the following:
            (A) Representatives provided for in the original charter of 
        the Advisory Committee.
            (B) A representative of the National Center for Health 
        Statistics.
    (c) Patient Safety Studies and Report.--
        (1) In general.--The Secretary shall designate an appropriate 
    agency within the Department of Health and Human Services to 
    coordinate existing studies on hospital readmissions of preterm 
    infants.
        (2) Report to secretary and congress.--Not later than 1 year 
    after the date of the enactment of this Act, the agency designated 
    under paragraph (1) shall submit to the Secretary and to Congress a 
    report containing the findings and recommendations resulting from 
    the studies coordinated under such paragraph, including 
    recommendations for hospital discharge and followup procedures 
    designed to reduce rates of preventable hospital readmissions for 
    preterm infants.

             TITLE II--NATIONAL PEDIATRIC RESEARCH NETWORK

    SEC. 201. SHORT TITLE.
    This title may be cited as the ``National Pediatric Research 
Network Act of 2013''.
    SEC. 202. NATIONAL PEDIATRIC RESEARCH NETWORK.
    Section 409D of the Public Health Service Act (42 U.S.C. 284h; 
relating to the Pediatric Research Initiative) is amended--
        (1) by redesignating subsection (d) as subsection (f); and
        (2) by inserting after subsection (c) the following:
    ``(d) National Pediatric Research Network.--
        ``(1) Network.--In carrying out the Initiative, the Director of 
    NIH, in consultation with the Director of the Eunice Kennedy 
    Shriver National Institute of Child Health and Human Development 
    and in collaboration with other appropriate national research 
    institutes and national centers that carry out activities involving 
    pediatric research, may provide for the establishment of a National 
    Pediatric Research Network in order to more effectively support 
    pediatric research and optimize the use of Federal resources. Such 
    National Pediatric Research Network may be comprised of, as 
    appropriate--
            ``(A) the pediatric research consortia receiving awards 
        under paragraph (2); or
            ``(B) other consortia, centers, or networks focused on 
        pediatric research that are recognized by the Director of NIH 
        and established pursuant to the authorities vested in the 
        National Institutes of Health by other sections of this Act.
        ``(2) Pediatric research consortia.--
            ``(A) In general.--The Director of NIH may award funding, 
        including through grants, contracts, or other mechanisms, to 
        public or private nonprofit entities for providing support for 
        pediatric research consortia, including with respect to--
                ``(i) basic, clinical, behavioral, or translational 
            research to meet unmet needs for pediatric research; and
                ``(ii) training researchers in pediatric research 
            techniques in order to address unmet pediatric research 
            needs.
            ``(B) Research.--The Director of NIH shall, as appropriate, 
        ensure that--
                ``(i) each consortium receiving an award under 
            subparagraph (A) conducts or supports at least one category 
            of research described in subparagraph (A)(i) and 
            collectively such consortia conduct or support such 
            categories of research; and
                ``(ii) one or more such consortia provide training 
            described in subparagraph (A)(ii).
            ``(C) Organization of consortium.--Each consortium 
        receiving an award under subparagraph (A) shall--
                ``(i) be formed from a collaboration of cooperating 
            institutions;
                ``(ii) be coordinated by a lead institution or 
            institutions;
                ``(iii) agree to disseminate scientific findings, 
            including from clinical trials, rapidly and efficiently, as 
            appropriate, to--

                    ``(I) other consortia;
                    ``(II) the National Institutes of Health;
                    ``(III) the Food and Drug Administration;
                    ``(IV) and other relevant agencies; and

                ``(iv) meet such requirements as may be prescribed by 
            the Director of NIH.
            ``(D) Supplement, not supplant.--Any support received by a 
        consortium under subparagraph (A) shall be used to supplement, 
        and not supplant, other public or private support for 
        activities authorized to be supported under this paragraph.
            ``(E) Duration of support.--Support of a consortium under 
        subparagraph (A) may be for a period of not to exceed 5 years. 
        Such period may be extended at the discretion of the Director 
        of NIH.
        ``(3) Coordination of consortia activities.--The Director of 
    NIH shall, as appropriate--
            ``(A) provide for the coordination of activities (including 
        the exchange of information and regular communication) among 
        the consortia established pursuant to paragraph (2); and
            ``(B) require the periodic preparation and submission to 
        the Director of reports on the activities of each such 
        consortium.
        ``(4) Assistance with registries.--Each consortium receiving an 
    award under paragraph (2)(A) may provide assistance, as 
    appropriate, to the Centers for Disease Control and Prevention for 
    activities related to patient registries and other surveillance 
    systems upon request by the Director of the Centers for Disease 
    Control and Prevention.
    ``(e) Research on Pediatric Rare Diseases or Conditions.--In making 
awards under subsection (d)(2) for pediatric research consortia, the 
Director of NIH shall ensure that an appropriate number of such awards 
are awarded to such consortia that agree to--
        ``(1) consider pediatric rare diseases or conditions, or those 
    related to birth defects; and
        ``(2) conduct or coordinate one or more multisite clinical 
    trials of therapies for, or approaches to, the prevention, 
    diagnosis, or treatment of one or more pediatric rare diseases or 
    conditions.''.

                    TITLE III--CHIMP ACT AMENDMENTS

    SEC. 301. SHORT TITLE.
    This title may be cited as the ``CHIMP Act Amendments of 2013''.
    SEC. 302. CARE FOR NIH CHIMPANZEES.
    (a) In General.--Section 404K(g) of the Public Health Service Act 
(42 U.S.C. 283m(g)) is amended--
        (1) by amending paragraph (1) to read as follows:
        ``(1) In general.--Of the amount appropriated for the National 
    Institutes of Health, there are authorized to be appropriated to 
    carry out this section and for the care, maintenance, and 
    transportation of all chimpanzees otherwise under the ownership or 
    control of the National Institutes of Health, and to enable the 
    National Institutes of Health to operate more efficiently and 
    economically by decreasing the overall Federal cost of providing 
    for the care, maintenance, and transportation of chimpanzees--
            ``(A) for fiscal year 2014, $12,400,000;
            ``(B) for fiscal year 2015, $11,650,000;
            ``(C) for fiscal year 2016, $10,900,000;
            ``(D) for fiscal year 2017, $10,150,000; and
            ``(E) for fiscal year 2018, $9,400,000.'';
        (2) by striking paragraph (2);
        (3) by redesignating paragraph (3) as paragraph (2); and
        (4) in paragraph (2), as so redesignated--
            (A) by striking ``With respect to amounts reserved under 
        paragraph (1)'' and inserting ``With respect to amounts 
        authorized to be appropriated by paragraph (1)''; and
            (B) by striking ``board of directors'' and inserting 
        ``Secretary in consultation with the board of directors''.
    (b) GAO Study.--Not later than 2 years after the date of enactment 
of this Act, the Comptroller General of the United States shall conduct 
an independent evaluation, and submit to the appropriate committees of 
Congress a report, regarding chimpanzees under the ownership or control 
the National Institutes of Health. Such report shall review and 
assess--
        (1) the research status of such chimpanzees;
        (2) the cost for the care, maintenance, and transportation of 
    such chimpanzees, including the cost broken down by--
            (A) research or retirement status;
            (B) services included in the care, maintenance, and 
        transportation; and
            (C) location;
        (3) the extent to which matching requirements have been met 
    pursuant to section 404K(e)(4) of the Public Health Service Act (42 
    U.S.C. 283m(e)(4)); and
        (4) any options for cost savings for the support and 
    maintenance of such chimpanzees.
    (c) Biennial Report.--Section 404K(g) of the Public Health Service 
Act (42 U.S.C. 283m(g)) is amended by adding at the end the following:
        ``(3) Biennial report.--Not later than 180 days after the date 
    enactment of this Act, the Director of the National Institutes of 
    Health shall submit to the Committee on Health, Education, Labor, 
    and Pensions and the Committee on Appropriations of the Senate and 
    the Committee on Energy and Commerce and the Committee on 
    Appropriations in the House of Representatives a report, to be 
    updated biennially, regarding--
            ``(A) the care, maintenance, and transportation of the 
        chimpanzees under the ownership or control of the National 
        Institutes of Health;
            ``(B) costs related to such care, maintenance, and 
        transportation, and any other related costs; and
            ``(C) the research status of such chimpanzees.''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
